Neos Therapeutics (NEOS) Reports In-Line Q2 EPS

Neos Therapeutics (NASDAQ: NEOS) reported Q2 EPS of ($0.83), in-line with the analyst estimate of ($0.83). Revenue for the quarter came in at $4.9 million versus the consensus estimate of $5.67 million.

For earnings history and earnings-related data on Neos Therapeutics (NEOS) click here.

You May Also Be Interested In

• Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
• Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
• Analog Devices (ADI) Tops Q3 EPS by 11c, Beats on Revenue; Offers Q4 Guidance